Citation Tools

Download PDFPDF

654 Real world incidence of grade III and higher adverse effects, emergency room utilization and hospital admissions during treatment with commonly used PD-1/PDL-1 targeting immune check point inhibitors

Download to a citation manager

Cite this article as:
Lia NL, Jafri SI, Shalaby K, et al
654 Real world incidence of grade III and higher adverse effects, emergency room utilization and hospital admissions during treatment with commonly used PD-1/PDL-1 targeting immune check point inhibitors